Clinical Trial

Fungal Vascular Graft Infections, French Multicenter Retrospective Study

Study acronym: FUNGIVAS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Fungal vascular graft and endograft infections (VGEIs) are rare but life-threatening infections. Best therapeutic management is unknown. This study retrospectively gathers fungal VGEIs from 12 university hospital centers in France over a 10 year's period in order to describe their epidemiology, clinical features, therapeutic management and outcomes. Focusing on Candida spp. VGEIs, we aim to determine prognosis factors associated with therapeutic management
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-19.
Trial Details
NCT Number NCT07143409
Lead Sponsor University Hospital, Bordeaux
Conditions Fungal Infection, Vascular Grafting
Enrollment 300 participants
Start Date 2026-01
Primary Completion 2027-05 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2025-12-16